BR9407415A - Compositions containing a non-steroidal anti-inflammatory agent amino acid salt of propionic acid and caffeine - Google Patents

Compositions containing a non-steroidal anti-inflammatory agent amino acid salt of propionic acid and caffeine

Info

Publication number
BR9407415A
BR9407415A BR9407415A BR9407415A BR9407415A BR 9407415 A BR9407415 A BR 9407415A BR 9407415 A BR9407415 A BR 9407415A BR 9407415 A BR9407415 A BR 9407415A BR 9407415 A BR9407415 A BR 9407415A
Authority
BR
Brazil
Prior art keywords
caffeine
compositions containing
steroidal anti
inflammatory agent
amino acid
Prior art date
Application number
BR9407415A
Other languages
Portuguese (pt)
Inventor
Sekhar Mitra
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR9407415A publication Critical patent/BR9407415A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9407415A 1993-09-07 1994-08-24 Compositions containing a non-steroidal anti-inflammatory agent amino acid salt of propionic acid and caffeine BR9407415A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11738993A 1993-09-07 1993-09-07
PCT/US1994/009582 WO1995007079A1 (en) 1993-09-07 1994-08-24 Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine

Publications (1)

Publication Number Publication Date
BR9407415A true BR9407415A (en) 1996-11-12

Family

ID=22372657

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9407415A BR9407415A (en) 1993-09-07 1994-08-24 Compositions containing a non-steroidal anti-inflammatory agent amino acid salt of propionic acid and caffeine

Country Status (6)

Country Link
EP (1) EP0717624A1 (en)
JP (1) JPH09502202A (en)
AU (1) AU7604194A (en)
BR (1) BR9407415A (en)
CA (1) CA2170485C (en)
WO (1) WO1995007079A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804560A (en) * 1995-01-06 1998-09-08 Sibia Neurosciences, Inc. Peptide and peptide analog protease inhibitors
US5863902A (en) * 1995-01-06 1999-01-26 Sibia Neurosciences, Inc. Methods of treating neurodegenerative disorders using protease inhibitors
IL126998A (en) * 1996-05-20 2003-12-10 Searle & Co Potassium, sodium or tris oxaprozin salt pharmaceutical formulations
CA2293605A1 (en) 1998-04-11 1999-10-21 Paolo Luca Maria Giorgetti Pharmaceutical preparations containing hydrosoluble ketoprofen salts and their application
NZ508490A (en) * 1998-07-09 2003-08-29 Warner Lambert Co Use of a combination of a GABA analog and caffeine as an analgesic
US6211246B1 (en) * 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
US20040115290A1 (en) 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
US7166641B2 (en) * 2002-10-02 2007-01-23 Yung Shin Pharmaceutical Industrial Co., Ltd. Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same
TWI313598B (en) * 2002-12-18 2009-08-21 Wyeth Corp Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines
US9149474B2 (en) * 2011-11-23 2015-10-06 Michael Leighton Compositions and methods for treating symptoms of inflammatory related conditions using a combination of an antihistamine and a stimulant
US9629847B2 (en) 2011-11-23 2017-04-25 Michael Leighton Compositions and methods for treating symptoms of inflammatory related conditions using a combination of an antihistamine and a stimulant
EP3406239B1 (en) * 2017-05-22 2021-10-20 Epifarma Srl Palatable ketoprofen lysine salt solutions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4420483A (en) * 1982-07-22 1983-12-13 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same
DE3328401A1 (en) * 1983-08-05 1985-02-21 Merckle GmbH, 7902 Blaubeuren INJECTABLE SOLUTION FOR TREATING INFLAMMATION
WO1991006295A1 (en) * 1989-11-06 1991-05-16 Sepracor, Inc. Analgesic composition containing optically pure s(+) flurbiprofen
US4994604A (en) * 1990-01-10 1991-02-19 Merck & Co., Inc. Formation and resolution of ibuprofen lysinate
JPH08501796A (en) * 1992-09-29 1996-02-27 メルク エンド カンパニー インコーポレーテッド Ibuprofen-caffeine formulation
WO1994014449A1 (en) * 1992-12-21 1994-07-07 The Procter & Gamble Company Compositions containing caffeine and s(+)-ibuprofen or s(+)-flurbiprofen or s(+)-ketoprofen
AU5995094A (en) * 1993-01-29 1994-08-15 Merck & Co., Inc. Ciclobenzaprine-caffeine combination as a muscle relaxant

Also Published As

Publication number Publication date
CA2170485C (en) 2000-11-07
CA2170485A1 (en) 1995-03-16
JPH09502202A (en) 1997-03-04
EP0717624A1 (en) 1996-06-26
WO1995007079A1 (en) 1995-03-16
AU7604194A (en) 1995-03-27

Similar Documents

Publication Publication Date Title
BR9407414A (en) Compositions containing a non-steroidal propionic acid anti-inflammatory agent amino acid salt and at least one decongestant an expectorant an antihistamine and an antitussive
BR9407415A (en) Compositions containing a non-steroidal anti-inflammatory agent amino acid salt of propionic acid and caffeine
HUT75089A (en) Compositions containing hyaluronic acid or it's derivatives and pharmaceutical active agent
KR100334973B1 (en) Topical composition containing hyaluronic acid and NSAID
ITMI931324A0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING SALTS OF S(+)-2-(4-ISOBUTYLPHENYL) PROPIONIC ACID WITH BASIC AMINO ACIDS
IL113433A0 (en) Tablet formulations comprising amoxycillin and salts of clavulanic acid
AU3590489A (en) Use of gamma-hydroxybutyric acid salts in the treatment of alcoholism and pharmaceutical compositions thereof
SG50636A1 (en) Substituted heterocyclylisoquinolinium salts and compositions and method of use thereof
GB9710644D0 (en) Asiatic acid derivatives it's manufacturing method and dermatological agent containing it
SG67283A1 (en) Sulphonic acid esters radiation-sensitive mixtures made therewith and their use
HU9502520D0 (en) Pharmaceutical use of substituted 4-phenyl-6-amino-nicotinic acid derivatives
KR920701213A (en) Methylenediphosphonic acid compound and anti-inflammatory agent using it as an active ingredient
DE69512929D1 (en) SALTS OF AMINO ALCOHOLS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BR9610733A (en) Compound processes for the preparation of it and for the treatment of a mammal pharmaceutical composition and use of a compound
BR9610388A (en) Pyrimidine compound or an acid addition salt thereof for the preparation of a pyrimidine and pharmaceutical formulation
AU2988992A (en) Ammonium salt of pyrimidyl-substituted benzoic acid and its use as a herbicide
NO180794B (en) Novel amidoalkyl and imidoalkylpiperazines and pharmaceutical preparations containing such compounds
AU7001796A (en) Benzoic acid compounds and medicinal use thereof
IL108920A0 (en) Acyloxyhexanoic acid derivatives and pharmaceutical compositions containing them
NO951933D0 (en) Pharmaceutical formulations of ibuprofen
BR9307697A (en) Compositions containing caffeine and s (+) - ibuprofen or s (+) - flubiprofen or s (+) - quetoprofen
HUP0001866A3 (en) Salts of l-carnitine and alkanoyl-l-carnitine derivatives with 2-aminoethanesulfonic acid and pharmaceutical compositions containing them
GB9304745D0 (en) Use of pharmaceutical formulations
DE69420346D1 (en) DERMATOLOGICAL PREPARATIONS AND NEW BENZOIC ACID DERIVATIVES
HU9601420D0 (en) Derivatives of 2,3,5,6-tetrafluorobenzoic acid and their use in combating pests

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
CKFC Appeal: appeal against refusal